J&J Must Pay $8 Billion in Case Over Male Breast Growth Linked to Risperdal: Jury

J&J Must Pay $8 Billion in Case Over Male Breast Growth Linked to Risperdal: Jury
The Johnson and Johnson logo is seen at an office building in Singapore, on Jan. 17, 2018. Reuters/Thomas White
|Updated:

NEW YORK—Johnson & Johnson must pay $8 billion in punitive damages to a man who previously won $680,000 over his claims that it failed to warn that young men using its antipsychotic drug Risperdal could grow breasts, a Philadelphia jury said on Tuesday.

The Philadelphia Court of Common Pleas jury’s verdict in favor of Nicholas Murray came in the first case in which a Pennsylvania jury had been able to consider awarding punitive damages in one of thousands of Risperdal cases pending in the state.